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Abstract
Background: Rigorous evaluations of health sector interventions addressing intimate partner violence (IPV) in
low- and middle-income countries are lacking. We aimed to assess whether an enhanced nurse-delivered
intervention would reduce IPV and improve levels of safety planning behaviors, use of community resources,
reproductive coercion, and mental quality of life.
Methods: We randomized 42 public health clinics in Mexico City to treatment or control arms. In treatment clinics,
women received the nurse-delivered session (IPV screening, supportive referrals, health/safety risk assessments) at
baseline (T1), and a booster counselling session after 3 months (T2). In control clinics, women received screening
and a referral card from nurses. Surveys were conducted at T1, T2, and T3 (15 months from baseline). Our main
outcome was past-year physical and sexual IPV. Intent-to-treat analyses were conducted via three-level random
intercepts models to evaluate the interaction term for treatment status by time.
Results: Between April and October 2013, 950 women (480 in control clinics, 470 in treatment clinics) with recent
IPV experiences enrolled in the study. While reductions in IPV were observed for both women enrolled in treatment
(OR, 0.40; 95% CI, 0.28–0.55; P < 0.01) and control (OR, 0.51; 95% CI, 0.36–0.72; P < 0.01) clinics at T3 (July to
December 2014), no significant treatment effects were observed (OR, 0.78; 95% CI, 0.49–1.24; P = 0.30). At T2 (July to
December 2013), women in treatment clinics reported significant improvements, compared to women in control
clinics, in mental quality of life (β, 1.45; 95% CI, 0.14–2.75; P = 0.03) and safety planning behaviors (β, 0.41; 95% CI,
0.02–0.79; P = 0.04).
Conclusion: While reductions in IPV levels were seen among women in both treatment and control clinics, the
enhanced nurse intervention was no more effective in reducing IPV. The enhanced nursing intervention may offer
short-term improvements in addressing safety planning and mental quality of life. Nurses can play a supportive role
in assisting women with IPV experiences.
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Background
The harmful public health impacts of male-perpetrated
intimate partner violence (IPV) against women have
been extensively documented, and include increased
vulnerability to poor mental health, HIV, sexual and
reproductive health problems, injury, and death [1, 2].
Globally, one in three women report experiencing such
violence, with greater prevalence found in low- and
middle-income countries (LMICs) [1].
The healthcare sector has long been highlighted for its
critical role in combating IPV. This is due in part to the
high prevalence of IPV among women who seek health
services and because healthcare providers have access to
this otherwise isolated population [3, 4]. However, suffi-
cient evidence does not exist to guide healthcare pro-
viders on how to most effectively meet the needs of such
women. A review of existing data from randomized trials
on routine screening of all women for IPV experiences
by healthcare providers indicated that reductions in IPV
and improvements in other health behaviors and out-
comes have not been consistent [5]. As such, even
though the World Health Organization provides clinical
guidelines for addressing IPV within primary care [6], it
does not support routine screening for IPV. Common
approaches within primary care settings include health-
care provider delivered education and counselling re-
garding IPV and related health concerns [7]. To date,
however, healthcare sector interventions within primary
care settings that focus on intervening with women
identified for IPV through screening have also yielded
mixed or sub-optimal findings regarding improvements
in mental health, reduced experiences of IPV, and help
seeking and safety planning behaviors [8–11].
Within LMICs, rigorous evaluations of health sector
interventions to address IPV are particularly scarce. Nu-
merous challenges exist in these contexts to implement-
ing health sector IPV programming and in conducting
rigorous evaluation trials that include overburdened
health facilities, high staff turnover, lack of private spaces
within healthcare facilities, victim-blaming attitudes held
by providers, and weak referral networks [3]. Public (i.e.,
government run) facilities may face additional challenges
with the follow-up of women since they may serve a
lower-income and more vulnerable portion of the popu-
lation than privately run healthcare facilities [12]. More-
over, as shown in a Mexico-based study [13], nursing
staff may experience IPV at a level similar to the general
population, which may pose personal obstacles to an
IPV response due to normalization of such behavior.
Regardless of such challenges, there is increasing evi-
dence of high-level commitment to addressing IPV
within governments, as Mexico ratified the Convention
to End All forms of Discrimination Against Women and
Children in 1981 and the Optional Protocol 2002 [14],
and in 2007, the Mexican government passed the
General Law on Women’s Access to a Life Free From
Violence [15]. The implementation of clinic-based IPV
programming in LMICs is also increasingly being docu-
mented, and their governments are also being called
upon to increase the prioritization of IPV within health
sector budgets and policies [3, 7, 16]. A recent review con-
ducted by the Pan American World Health Organization
of clinical guidelines for responding to IPV in 12 out of 18
Latin American and Caribbean countries also underscored
the importance of increased training of healthcare pro-
viders [17]. To optimally inform such efforts, data from
rigorous evaluations of health sector responses to IPV
within LMICs are urgently needed.
The current study aimed to address this important
gap in the intervention literature through conducting
a clinic-based randomized controlled trial (RCT) to
assess the impact of a nurse-delivered intervention to
women identified as experiencing recent IPV through
screening within public health clinics in Mexico City.
The intervention aimed to reduce IPV, improve use
of community resources, increase safety planning, de-
crease reproductive coercion, and improve mental
quality of life more so than the provision of resources
alone.
Methods
Study design
This study is a cluster-randomized controlled trial that
occurred between 2012 and 2015 across 42 public health
clinics operated by the Ministry of Health (MoH) in
Mexico City. A full study protocol is described elsewhere
[12]. Briefly, in April 2013, the study began a rolling
recruitment and baseline survey administration (Time 1;
T1). Women were then invited to participate in a 3-
month follow-up survey (Time 2; T2) and a 15-month
follow-up survey (Time 3; T3). The 15-month follow-up
period was selected to allow for the research team to
assess for past-year changes in IPV between T2 and T3.
All survey data were collected through the Computer
Assisted Self-Interview on laptops, where trained re-
search assistants read each item and response choices
aloud to participants, and entered the response choice
on participants’ behalf. This approach, versus audio
computer assisted interviewing was implemented based
on piloting, where participants indicated greater comfort
with the research assistant-assisted interview. Interviews
were completed in private areas of the clinics and
research assistants were available for questions through-
out the surveys.
The T2 survey was conducted before the booster
counseling session and women received US$15 for their
time in the form of a gift card. At T3, women received
US$20 in the form of a gift card.
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At all data collection points, women were asked to
provide informed consent. Specifically, in a private lo-
cation within the clinic, trained research assistants told
eligible women that they were invited to take part in a
research study to learn about women’s health, family,
and relationships, including difficult issues like vio-
lence. They were told that they would be invited to take
part in three surveys in total (with time points speci-
fied), that they could withdraw at any time and that
their responses would be kept private, and that their
decisions to participate or not would not impact the
care they receive at the health clinic. They were also
told that the clinic they were visiting was part of a
group of clinics in Mexico City that were participating
in the study, and that for the purpose of the study,
clinics were randomly assigned to offer one of two
types of services: comprehensive services to assist
women with health and family issues or a shorter ver-
sion of the services. Women were told that neither the
research team nor the nurse would be able to share
whether their clinic would be offering comprehensive
services or the shorter version.
Mexico-based research staff (all of whom had at least an
undergraduate degree) were also trained on research and
ethical protocols that adhered to international standards
on violence against women research, including interven-
tion research [18, 19], and were approved by the Yale
School of Public Health (#1202007993), George Mason
University (protocol # 704016–4), Innovations for Poverty
Action (#00006083), and the Mexico City MoH (protocol
#1470-6812) human subjects committees.
Participants
A total of 29,947 women presenting at the participating
42 clinics (details of clinic selection are described in the
“randomization and masking” section) were approached
and screened for eligibility (see Consort Diagram,
Fig. 1). Criteria for participation included being be-
tween 18 and 44 years of age, currently in a heterosex-
ual relationship, reporting experiences of physical and/
or sexual IPV within the past year in research assistant-
administered screening, and were not pregnant or were
pregnant in their first trimester. Based on feedback
from piloting the assessment, the IPV screening tool
consisted of 11 questions in order to build rapport be-
tween the research assistant and the participant. The
first nine questions were in regards to the woman’s
health and relationship with her partner, including
emotional abuse, as directly asking about physical or
sexual IPV at the very beginning of the assessment was
rendered as too sensitive during our piloting phase.
Based on feedback from focus groups carried out with
IPV survivors at a community domestic violence
agency, concrete examples of physical and sexual IPV
were included in the questions. More details on this
screening tool can be viewed in the study protocol [12].
Exclusion criteria included having plans to relocate in
the next 2 years or having an easily recognizable cog-
nitive impairment.
Randomization and masking
Clinics were eligible to participate if they were Type III
clinics, which are larger government-led community
health clinics that provide more comprehensive care and
services (in comparison to smaller Types I and II
clinics). These Type III clinics serve a lower income
population within Mexico City. A total of 60 Type III
clinics were assessed for eligibility. Three clinics were
excluded from the study; two were eliminated to reduce
the threat of contamination (i.e., were located in close
proximity to a MoH hospital that offered IPV program-
ming) and one was eliminated given that it was located
within a small catchment area with few community
services. Of these 57 eligible clinics, 42 were randomly
selected using excel, based on sample size calculations.
Health centers selected were stratified by city zone and
borough using an excel file. Health centers were
assigned a number using the RAND command to
randomly select the health centers [20]. Specifically, to
randomly select the 42 health centers, all centers were
assigned random numbers in Excel and sorted from
smallest to largest; health centers were selected based on
city zone and in order of their random number. More
details on the sample size and power calculations can be
reviewed in a previously published protocol paper [12].
The 42 health centers were stratified by zone and dis-
trict, and randomly assigned to treatment or control
using STATA [21]; more details can be reviewed in the
previously published protocol paper [12]. To ensure that
the neighborhoods where the clinics were located were
similar in terms of degree of urbanization and socioeco-
nomic status, data from the National Institute of Statistics
were used to create a socioeconomic index variable based
on borough-level aggregate data on levels of education,
number of rooms in the house, concrete floor, household
items (television, internet, car, refrigerator, computer, and
bathrooms). Treatment and control clinics did not differ
significantly at the 5% level on these variables. Participants
were blinded to their study arm, while nurses, clinic staff,
and the research team were not.
Procedures
The intervention consisted of the following components
as delivered by nurses (Table 1): (1) integrated IPV and
health screening assessment; (2) supportive care; (3)
safety planning and harm reduction counseling, includ-
ing reproductive health concerns; (4) assisted referrals;
and (5) a booster counseling session at 3 months after
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the initial screening and counseling session. Women at
the treatment clinics received the intervention from
nurses who were eligible and selected to participate in a
3-day training that covered topics related to IPV, safety
planning, reproductive coercion, and community re-
source referrals, and was developed jointly by the
research team and the International Planned Parenthood
Federation/Western Hemisphere Region [22]. Nurses
from all 42 health clinics were invited to participate in
the training based on whether they were morning shift
nurses (due to the walk-in basis of appointments and
afternoon shifts not occurring at all clinics) and not a
field nurse (nurses who work in the community and thus
have limited hours at health clinics). Out of 379 eligible
nurses, 197 (52.0%) were trained for the study. As part
of the training, the research team also conducted an
additional three clinic visits to practice via supervised
role-playing exercises. Women in control clinics received
the MoH standard of care, which consisted of a referral
card containing information on IPV and available MoH
and community services. Additional details regarding
the nurse selection and participation, development, de-
livery, and components of the intervention can be found
in the study protocol [12].
Outcomes
The primary outcome was physical and sexual IPV. At
T1, the time reference was past-year, T2 referred to only
experiences of IPV in the past 3 months, and T3 re-
ferred to both past year and past 3 months. Any affir-
mative response to a binary item in both the physical
and sexual IPV scales, as drawn from the World Health
Fig. 1 Consort diagram
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Organization Multi-Country Study on Domestic Vio-
lence and Women’s Health (see Additional file 1, 2, 3
and 4 for complete list of IPV items) [23], was coded as
experiencing physical and sexual IPV. Secondary mea-
sures included reproductive coercion, whereby any posi-
tive response to an item was coded as experiencing
reproductive coercion [24], use of community resources
[25], safety planning activities [25], and SF-12 quality of
life measure (mental quality of life) [26]. Physical quality
of life was not an outcome because we did not expect
changes in physical quality of life based on the interven-
tion. All measures were piloted and safety planning mea-
sures and quality of life scales were adapted as
appropriate. For example, this survey employed a 13-
item safety planning scale that removed two original
items related to having insurance policies available and
social security numbers, which were not relevant for this
context. The quality of life scale was also adapted from
five-point to four-point Likert scales based on pilot feed-
back. Transformed composite scores for SF-12 quality of
life measure were respectively calculated for mental
health scores as a continuous outcome [27].
Statistical analysis
To account for the clustering in the data structure where
baseline and follow-up outcomes were repeated mea-
sures nested within individuals, which were nested
within health clinics, multilevel analysis was conducted
to model changes of IPV and related outcomes by treat-
ment status. Specifically, a three-level random intercepts
model was conducted to evaluate the interaction term
between treatment status and time (e.g., T1 vs. T3) with
the use of random effects to adjust for both correlation
between the time points within individuals and cluster-
ing among individuals nested within health clinics. We
employed the generalized mixed model in GLIMMIX
procedure in SAS v9.2 [28] to fit the multilevel model. A
significant treatment by time interaction term suggested
statistically significant differential effects of treatment on
changes in outcomes from T1 to T3. Covariates deemed
substantively important based on prior literature or signifi-
cant between-group differences found at baseline were
adjusted in the multiple regression models. Odds ratios
(ORs), 95% confidence intervals (CIs), and P values were
used to assess the significance of the regression coefficients
Table 1 Components of interventions for treatment and control clinics
Intervention component Treatment clinics Control clinics
Integrated IPV and health screening Women were screened for IPV including
emotional, physical, and sexual violence,
as part of a general health assessment.
Integrated IPV and health Screening,
Supportive Care, Business-sized Referral
Card, Booster session at 3 months where
the referral card was redistributed.
Supportive care Nurses were trained to provide non-judgmental
and empathetic counseling.
Safety planning and harm reduction counseling Nurses discussed safety planning measures
with women, including escape routes or
places of refuge, packing and storing a bag
with important belongings, memorizing phone
numbers, talking to children about what to do
in cases of violence, and staying away from
rooms with weapons. Harm reduction counseling
included the partners’ use of alcohol and illicit
drugs, how to remove weapons, options for
protecting reproductive health, such as
protecting against unplanned pregnancy,
sexually transmitted infections, and other
individual-specific health risks.
Supportive referrals Nurses provided information regarding local
and free IPV resources, in accordance with their
specific needs. Nurses facilitated access and
utilization by either contacting programs
together, or by providing women with
step-by-step directions. For the latter, nurses
provided specific names of staff members at
programs as opposed to a generic address.
This information was also provided via
business-sized referral cards.
Booster counseling sessions at 3 months (T2) Components of above screening, referral,
safety planning and harm reduction were
reviewed and redelivered to program
participants. Sessions occurred in the clinic
during an appointment that was scheduled
during T1.
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for models with binary outcomes, while β, 95% CIs,
and P values were used for continuous outcomes. Specific-
ally, we first evaluated whether there was significant
change of outcome within each treatment group, then we
compared whether such outcome change differed by treat-
ment status. Because the main research question was to
investigate the differential treatment effect by group
status, β and P values were used for evaluating the signifi-
cance of the treatment by time interaction terms.
To assess nurse fidelity to the intervention protocol,
exit interviews with women in both treatment and con-
trol clinics were conducted immediately after their meet-
ing with nurses at T1. All participants were approached,
and 2.6% (n = 25) of study participants did not complete
the exit survey. Of these 25 participants, 16 completed
the survey, but left the health center before meeting with
the nurse. The remaining nine participants declined par-
ticipation in the exit interview due to insufficient time.
A high adherence to the intervention protocol was ob-
served in both treatment and control exit interviews
(treatment mean =15.3 out of 16 possible points; control
mean = 5.69 out of 6 possible points).
Results
The resulting sample size was 950 participants (480 in
control clinics; 470 in treatment clinics) at T1 (participa-
tion rate of 83.6% among women who could be deter-
mined to be eligible). See Fig. 1 for more details.
At T2, 780 women, or 82.1% of the baseline sample,
participated in the survey. There was no differential
attrition by study arms for T1 demographics nor IPV
status at T2. The primary reason for loss to follow-up
was not being able to be located by the research team,
followed by being a “no-show”, and refusal to participate.
In order to reduce loss to follow-up, all women received
monthly phone call reminders and home visits for their
future appointments [12]. Regardless of whether a
woman participated in T2, all women were invited to
complete the T3 survey. Of the original sample, 717
women completed the T3 survey, or 75.5% of the base-
line sample. Fifty-two women who could not be located
during T2 participated in T3. Differential attrition in
past month physical and sexual IPV was observed be-
tween T2 and T3; control participants who were lost to
follow-up from T2 to T3 reported more past month phys-
ical and sexual IPV at T2 than treatment participants; no
other differences regarding attrition were observed. Over-
all, 69.3% of women included in the baseline participated
in both periods of data collection.
Demographics of participants are presented in Table 2
for the overall sample and by treatment group. No statis-
tically significant demographic differences were found
between treatment arms (thus randomization was largely
successful), nor were there any statistically significant
differences in study outcomes reported at T1. Consider-
ing prior literature and the between-group baseline
comparisons, we further adjusted for age, number of
children, and birthplace in the subsequent multiple re-
gression models.
Intention-to-treat analysis indicated no significant time
by treatment impact for past year IPVs, reproductive co-
ercion, safety planning behaviors, use of community re-
sources, and mental quality of life (Table 3). Both
intervention and control participants reported significant
reductions in past year IPV (OR, 0.40; 95% CI, 0.28–
0.55; P < 0.01 and OR, 0.51; 95% CI, 0.36–0.72; P < 0.01,
respectively), while only treatment participants reported
significant reductions in reproductive coercion (OR, 0.56;
95% CI, 0.37–0.83; P < 0.01). Both intervention and con-
trol participants reported significant increases in safety
planning (β, 0.88; 95% CI, 0.58–1.18; P < 0.01 and β,
0.52; 95% CI, 0.20–0.83; P < 0.01, respectively) and im-
provement in mental quality of life (β, 2.34; P < 0.01
and β, 1.46; P < 0.01, respectively), while only women in
treatment clinics reported significant improvements in
use of community resources (β, 0.20; 95% CI, 0.08–
0.31; P < 0.01).
Intention-to-treat analyses found a significant differen-
tial increase of safety planning behaviors (β, 0.41; 95%
CI, 0.02–0.79; P = 0.04) and improvement of mental
quality of life (β, 1.45; 95% CI, 0.14–2.75; P = 0.03) at T2
among the treatment group relative to the control
(Table 4). Both treatment and control participants re-
ported significant increases in use of community
resources.
Intention-to-treat analyses found no significant differ-
ential effects for IPVs, reproductive coercion, and mental
quality of life when comparing T2 and T3 responses
(Table 5). Details of the regression coefficients in the
final adjusted models with and without the time by
treatment interaction are provided in Additional file 1.
Discussion
In this RCT of women with recent experiences of IPV
who sought healthcare in public health clinics within
Mexico City, significant reductions in IPV and signifi-
cant increases in safety planning, use of community re-
sources, and mental quality of life were seen, regardless
of exposure to control or treatment conditions. How-
ever, the nurse-delivered counselling sessions did not
significantly improve levels of IPV, reproductive coer-
cion, safety planning behaviors, use of community re-
sources, and mental quality of life compared with
women who were in the control arm. This was the first
RCT, to our knowledge, to evaluate a health sector inter-
vention to address IPV and other health outcomes
within a LMIC, on such a large scale and outside of
antenatal care settings. While the current trial is one of
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Table 2 Baseline (T1) characteristics of study sample, by treatment arm (N = 950)
Treatment (n = 470) Mean
(SD) or n (%)
Control (n = 480) Mean
(SD) or n (%)
t statistic or χ2 P value
Age, years 30.12 (7.28) 29.60 (7.03) 1.12 0.26
Number of children 2.28 (1.18) 2.13 (1.22) 1.98 0.05
Partner’s age minus woman’s age, years 3.19 (5.90) 3.50 (6.66) 0.78 0.44
Previously screened for IPV in healthcare setting 43 (9.15%) 52 (10.86%) 0.77 0.38
Reason for visita 1.25 0.54
General appointment 108 (22.98%) 124 (25.83%)
Gynecological appointment 34 (7.23%) 36 (7.50%)
Other 328 (69.79%) 318 (66.25%)
Legal status 3.07 0.38
Single 22 (4.68%) 35 (7.29%)
Married 112 (23.83%) 115 (23.96%)
Common law marriage 321 (68.30%) 317 (66.04%)
Separated/Divorced 15 (3.19%) 13 (2.71%)
Birthplace 1.35 0.25
Mexico City 344 (73.19%) 335 (69.79%)
State of Mexico 45 (9.57%) 39 (8.13%)
Another state/country 81 (17.23%) 106 (22.08%)
Schooling 4.33 0.63
No schooling 16 (3.40%) 10 (2.08%)
Primary 99 (21.06%) 108 (22.50%)
Secondary 196 (41.70%) 205 (42.50%)
High school 100 (21.28%) 86 (17.92%)
Technical degree 35 (7.45%) 45 (9.38%)
College 22 (4.68%) 24 (5.00%)
Post-graduate 2 (0.43%) 2 (0.42%)
Monthly income MXN (USD)a 3.33 0.19
Under $2 K (133) 170 (61.59%) 148 (54.01%)
$2 K to $4 K (133–266) 86 (30.80%) 99 (36.13%)
$4 K+ (266+) 21 (7.61%) 27 (9.85%)
Religiona 3.03 0.39
Catholic 385 (81.91%) 385 (80.38%)
Christian 29 (6.17%) 36 (7.52%)
None 35 (7.45%) 28 (5.85%)
Other 21 (4.47%) 30 (6.26%)
Past-year IPV
Physical violence 454 (96.60%) 470 (97.92%) 1.56 0.21
Sexual violence 184 (39.15%) 162 (33.89%) 2.83 0.09
Physical and sexual violence 168 (35.74%) 152 (31.67%) 1.77 0.18
Reproductive coercion 106 (34.64%) 112 (34.70%) 0.00 0.97
Safety planning, past 12 months 3.16 (2.85) 3.16 (2.91) 0.02 0.99
Use of community resources, past 6 months 0.30 (0.68) 0.30 (0.78) 0.03 0.97
Quality of life score (mental) 35.14 (7.45) 35.29 (7.90) 0.31 0.76
an values do not total to 950 due to missing values
IPV intimate partner violence
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a limited number of trials of a nurse-delivered interven-
tion response to IPV within a LMIC, the findings mirror
primary care and/or nurse-delivered interventions in
higher income settings [5, 9, 10, 25]. Importantly, this
research demonstrates that it is possible to rigorously
evaluate a health sector IPV intervention program with
vulnerable populations in a LMIC setting within an
urban mega-city.
More research is needed as to why the standard of
care (control) yielded the same impacts as the enhanced
nurse-delivered intervention. The participants in this
trial consisted of a highly vulnerable population, namely
lower income women with recent IPV experiences.
Thus, exposure to even a low-dose intervention may
have yielded improvements for both control and treat-
ment participants. Similar reductions in both arms have
been found in a previous screening trial in Canada [29]
and with Mexican American women within the United
States [25].
Qualitative interviews (data not shown) with control
participants also suggest that the experiences of being
asked about IPV within a healthcare setting by the sur-
vey, research staff and the nurses also triggered self-
reflection and behavioral changes within this vulnerable
population. Due to ethical reasons, a “pure” control arm
was not included in this study, and the control arm’s
standard of care was more than most women would
typically receive within these clinics. In addition, while
overall loss to follow-up was minimal, there was differ-
ential attrition between control and treatment groups,
such that women in the control arm who dropped out of
the study experienced more IPV. Thus, since these
women were no longer in the 15-month follow-up, the
effects of the intervention may be attenuated.
Table 3 Distribution of study outcomes at T1 and T3, by treatment arm and effect estimates of primary and secondary outcomes
(Intent to Treat Analysis)
T1-T3 Comparison Treatment X Time interaction
Treatment type Baseline (T1)
N (%)
Endline (T3)
N (%)
OR (95% CI) p-value OR (95% CI) p-value
Physical and Sexual IPV
(past year)
Intervention 168/470
(35.7%)
72/365
(19.7%)
0.40 (0.28, 0.55) <0.01* 0.78 (0.49, 1.24) 0.30
Control 152/480
(31.7%)
72/352
(20.5%)
0.51 (0.36, 0.72) <0.01*
Physical IPV
(past year)
Intervention 454/470
(96.6%)
209/365
(57.3%)
0.05 (0.03, 0.08) <0.01* 1.48 (0.63, 3.49) 0.37
Control 470/480
(97.9%)
210/351
(59.8%)
0.03 (0.016, 0.06) <0.01*
Sexual IPV
(past year)
Intervention 184/470
(39.2%)
94/365
(25.8%)
0.47 (0.34, 0.64) <0.01* 0.90 (0.57, 1.41) 0.65
Control 162/478
(33.9%)
81/351
(23.1%)
0.54 (0.39, 0.75) <0.01*
Reproductive Coercion
(past year)
Intervention 106/306
(34.6%)
52/226
(23.0%)
0.56 (0.37, 0.83) <0.01* 0.71 (0.41, 1.23) 0.22
Control 112/322
(34.8%)
65/220
(29.6%)
0.79 (0.54, 1.17) 0.23
Treatment type Baseline (T1)
Mean (SD)
Endline (T3)
Mean (SD)
beta (95% CI) p-value beta (95% CI) p-value
Use of community
resourcesa (past 6 mos)
Intervention N = 470,
0.30 (0.68)
N = 365,
0.51 (1.10)
0.20 (0.08, 0.31) <0.01* 0.08 (-0.09, 0.24) 0.36
Control N = 479,
0.30 (0.78)
N = 361,
0.43 (1.04)
0.11 (-0.003, 0.23) 0.056
Safety planning behaviorsa
(ever T1 vs. past 12 mos T3)
Intervention N = 470,
3.16 (2.85)
N = 365,
4.08 (3.34)
0.88 (0.58, 1.18) <0.01* 0.36 (-0.07, 0.79) 0.10
Control N = 479,
3.16 (2.91)
N = 351,
3.70 (3.24)
0.52 (0.20, 0.83) <0.01*
Quality of Lifea
(mental past month)
Intervention N = 470,
35.14 (7.45)
N = 363,
37.20 (7.69)
2.34 (1.41, 3.27) <0.01* 0.90 (-0.43, 2.24) 0.19
Control N = 479,
35.39 (7.80)
N = 350,
36.42 (7.99)
1.46 (0.48, 2.44) <0.01*
a Outcome variable is treated as a continuous variable, therefore regression coefficient beta and 95% confident intervals of beta are reported
* Denotes significant finding
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Trial findings indicate that the nurse-delivered inter-
vention yielded statistically significant improvements in
safety planning and mental quality of life at 3 months
following baseline. These intervention effects, however,
were not observed at T3. It may be that women in the
intervention arm had an initial uptake in implementing
safety planning behaviors that were one-time actions. For
instance, safety planning behaviors, such as establishing a
code with neighbors, memorizing important phone num-
bers, or packing an emergency bag, may have been im-
plemented at a higher level by treatment women in
comparison to control women. Then, once implemented,
these safety planning behaviors were not repeated on an
ongoing basis, and thus were not captured at T3, which
focused on past year behaviors only. Another explanation
for the lack of significant intervention effects on safety
planning behaviors may be due to the context of Mexico
City. Mexico City is an earthquake-prone area and thus all
residents are in the routine habit of planning for emer-
gencies [30]. Thus, the concept of safety planning may
have resonated with both treatment and control women
throughout the duration of the study, as was suggested by
qualitative interviews (data not shown).
Short-term, but not long-term, significant treatment
effects on improved mental quality of life may have been
observed due to women’s initial feelings of support and
validation upon receipt of the nurse-delivered interven-
tion. However, these initial impacts at T2 may not have
persisted due to lack of ongoing structural support outside
of the nurse delivered intervention, as this intervention
did not address social norms or community context, or
seek to improve other support services for women experi-
encing violence. A 7-year, US-based prospective study of
women who sought social services for IPV experiences
yielded similar short- and long-term findings regard-
ing mental health [31]. Other health sector-based
RCTs in non-LMIC settings have shown mixed find-
ings regarding improvements in mental health, includ-
ing quality of life [5, 10, 32].
The findings of this randomized trial must be consid-
ered within the context of important limitations. In
addition to the aforementioned limitations, the interven-
tion was only delivered by select nurses and was not a
system-wide intervention. While guidelines recommend
moving more towards a system-wide approach to pre-
venting and responding to IPV within the health sector,
such an approach was not feasible in our study setting.
It should also be noted that neither the researchers nor
the clinic staff were blinded to their study condition.
Thus, there may be a possibility of contamination, as
control nurses may have provided more comprehensive
counselling to participants beyond what the study proto-
col asked of them. The current study also remained in
frequent contact and offered monetary compensation to
all study participants as a means to reduce attrition. The
attrition rate of this RCT was low; however, ongoing
contact from the research team may have also promoted
behavior change for participants in both control and
treatment arms. Significant findings pertaining to safety
planning and mental quality of life, furthermore, may be
restricted to statistical significance only, as the clinical
significance of such changes are currently unclear.
Finally, behaviors may have been carried out but not
captured by the survey items due to the time period of
assessments. For instance, use of community resources
was only assessed as “in the past 6 months”. This may
have underestimated the impact of the intervention on
these behaviors.
These limitations notwithstanding, strengths of this trial
include a large sample size, successful randomization, low
attrition, high fidelity to the intervention by the nurses,
the ability to conduct this work in a complex setting, and
Table 4 Distribution of study outcomes at T1 and T2 (3 months), by treatment group and effect estimates of secondary outcomes
(intent-to-treat analysis)
Pre/Post T1–T2 comparison Treatment × time
interaction to examine
intervention effects
Treatment type Baseline (T1)
n Mean (SD)
Midline (T2)
n Mean (SD)
β (95% CI) P value β (95% CI) P value
Use of community
resourcesa (ever used
measured at T1 vs.
3 months T2)
Intervention n = 470, 0.75 (1.16) n = 387, 0.61 (1.22) −0.16 (−0.30 to −0.02) 0.02* 0.13 (−0.05 to 0.32) 0.17
Control n = 479, 0.73 (1.17) n = 393, 0.47 (1.18) −0.30 (−0.42 to −0.17) <0.01*
Safety planning behaviorsa
(ever done at T1 vs.
3 months T2)
Intervention n = 470, 3.16 (2.85) n = 387, 3.70 (3.11) 0.48 (0.22–0.75) <0.01* 0.41 (0.02– 0.79) 0.04*
Control n = 479, 3.16 (2.91) n = 393, 3.31 (3.03) 0.08 (−0.19 to 0.36) 0.56
Quality of lifea
(mental, past month)
Intervention n = 470, 35.14 (7.45) n = 386, 37.85 (8.30) 2.85 (1.91–3.79) <0.01* 1.45 (0.14– 2.75) 0.03*
Control n = 479, 35.29 (7.90) n = 392, 36.49 (7.63) 1.40 (0.49–2.31) <0.01*
aOutcome variable is treated as a continuous variable, therefore regression coefficient β and its 95% confidence interval are reported
* Denotes significant finding
IPV intimate partner violence
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long term follow-up. We also adhered to strict ethical
guidelines for conducting research on IPV.
Conclusions
These study findings do not lend support to utilizing an
enhanced nurse delivered intervention over standard of
care to reduce IPV. However, it should be noted that
pre-post improvements in outcomes in both control and
treatment arms do lend support to the idea that nurses,
and more broadly, the health sector, can play a supportive
role in assisting women with IPV experiences. Moreover,
findings highlight that this nurse-delivered intervention
has the potential to improve mental health and safety
planning behaviors in the short term, but not in the
longer term, although the extent to which statistically
significant findings translate to clinically significant
findings is currently not clear. Future work should
consider examining interventions that involve healthcare
provider responses bundled with other sectors (e.g., eco-
nomic empowerment, policy, housing, social norms) to
more holistically address the needs of women with IPV
experiences within LMICs.
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Additional file 1: Items used to assess IPV. (DOCX 14 kb)
Additional file 2: Table 2: Regression coefficients of adjusted models
with and without treatment by time interaction terms (T1 and T3).
(XLSX 11 kb)
Additional file 3: Table 3: Regression coefficients of adjusted models
with and without treatment by time interaction terms (T1 and T2).
(XLSX 9 kb)
Additional file 4: Regression coefficients of adjusted models with and
without treatment by time interaction terms (T2 and T3, controlling for
baseline measure at T1). (XLSX 11 kb)
Table 5 Distribution of study outcomes at T2 and T3, by treatment group and effect estimates of primary and secondary outcomes
(Intent to Treat Analysis)
T2-T3 Comparison Treatment X Time interaction
Treatment type Midline (T2)
N (%)
Endline (T3)
N (%)
OR (95% CI) p-value OR (95% CI) p-value
Physical and Sexual IPV
(past month)
Intervention 33/387
(8.5%)
29/365
(8.0%)
0.84 (0.49, 1.45) 0.53 0.55 (0.26, 1.13) 0.10
Control 60/393
(15.3%)
29/352
(8.2%)
0.50 (0.31, 0.83) <0.01*
Physical IPV
(past month)
Intervention 138/386
(35.8%)
91/365
(24.9%)
0.59 (0.43, 0.82) <0.01* 0.82 (0.52, 1.28) 0.380
Control 173/393
(44.0%)
97/351
(27.6%)
0.48 (0.35, 0.66) <0.01*
Sexual IPV
(past month)
Intervention 56/386
(14.5%)
43/365
(11.8%)
0.70 (0.44, 1.11) 0.12 0.81 (0.43, 1.53) 0.52
Control 70/393
(17.8%)
41/351
(11.7%)
0.62 (0.39, 0.98) 0.04*
Reproductive Coercion
(past month)
Intervention 52/244
(21.3%)
31/225
(13.8%)
0.55 (0.32, 0.95) 0.03* 1.24 (0.59, 2.63) 0.57
Control 51/255
(20.0%)
33/217
(15.2%)
0.68 (0.40, 1.15) 0.16
Treatment type Midline (T2)
Mean (SD)
Endline (T3)
Mean (SD)
beta (95% CI) p-value beta (95% CI) p-value
Use of community resourcesa
(past 3 mos)
Intervention N = 387,
0.61 (1.22)
N = 365,
0.27 (0.87)
-0.33 (-0.45, -0.21) <0.01* -0.13 (-0.32, 0.05) 0.15
Control N = 393,
0.47 (1.18)
N = 351,
0.27 (0.77)
-0.21 (-0.35, -0.07) <0.01*
Safety planning behaviorsa
(past 3 mos)
Intervention N = 387,
3.70 (3.11)
N = 365,
2.60 (2.85)
-1.08 (-1.38, -0.78) <0.01* -0.28 (-0.71, 0.16) 0.21
Control N = 393,
3.31 (3.03)
N = 351,
2.40 (2.64)
-0.83 (-1.15, -0.52) <0.01*
Quality of Life (mental)a
(past month)
Intervention N = 386,
37.85 (8.30)
N = 363,
37.20 (7.69)
-0.50 (-1.48, 0.49) 0.32 -0.51 (-1.89, 0.88) 0.47
Control N = 392,
36.49 (7.63)
N = 350,
36.42 (7.65)
0.01 (-0.97, 1.00) 0.98
a Outcome variable is treated as a continuous variable, therefore regression coefficient beta and its 95% confidence interval are reported
* Denotes significant finding
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